A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1997
12/02/1997	US5693804 Substituted 1-aryl-3-piperazin-1'-yl propanones
12/02/1997	US5693795 Process for the manufacture of 4H-imidazo 1,5-A! 1,4!benzodiazepines
12/02/1997	US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
12/02/1997	US5693762 Humanized immunoglobulins
12/02/1997	US5693761 Genetic engineering; complementarity zones
12/02/1997	US5693753 Method of isolating βA4 peptide species ending at carboxy-terminals residue 42 using monoclonal antibody 369.2B
12/02/1997	US5693676 Using nitroglycerin to treat anal fissures or ulcers, hemorrhoids, levator spasms
12/02/1997	US5693669 Dissolving tilidine in mixture of isopropanol and water, mild heating and stirring while adding phosphoric acid, then cooling and crystallization yields stable tilidine dihydrogen orthophosphate
12/02/1997	US5693665 Alkylated (hetero) cyclic compounds
12/02/1997	US5693655 Substituted di-indolylpiperidines for treatment of nervous system disorders
12/02/1997	US5693653 Administering an antidepressants
12/02/1997	US5693649 N-substituted azaheterocyclic carboxylic acids and esters thereof
12/02/1997	US5693642 Anxiolytic and hypotensive agents; antidepressants; psychological disorders; controllers of sleep/wake cycle, eating and sexual disorders
12/02/1997	US5693630 Phenylethyl and phenylpropylamines
12/02/1997	US5693614 Drug for the treatment of senile dementia of the ischemic and hypoglycemic types
12/02/1997	US5693312 Pharmaceutical composition having analgesic activity
12/02/1997	CA2010011C N-phenyl-n-(4-piperidinyl) amides useful as analgesics
11/1997
11/30/1997	CA2205770A1 Process for producing paroxetine
11/27/1997	WO1997044454A2 Human phospholipase inhibitor
11/27/1997	WO1997044360A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044359A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
11/27/1997	WO1997044339A1 Antagonists of gonadotropin releasing hormone
11/27/1997	WO1997044337A1 Benzofuran carboxamides and their therapeutic use
11/27/1997	WO1997044326A1 Aryl pyrimidine derivatives
11/27/1997	WO1997044045A1 Malatonin in combination with analgesics
11/27/1997	WO1997044041A1 Antagonists of gonadotropin releasing hormone
11/27/1997	WO1997044040A1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
11/27/1997	WO1997044039A1 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
11/27/1997	WO1997044038A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
11/27/1997	WO1997044037A1 Antagonists of gonadotropin releasing hormone
11/27/1997	WO1997044020A1 Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
11/27/1997	CA2255838A1 Melatonin in combination with analgesics
11/27/1997	CA2255705A1 Aryl pyrimidine derivatives
11/27/1997	CA2255650A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
11/27/1997	CA2254974A1 Antagonists of gonadotropin releasing hormone
11/27/1997	CA2254769A1 Antagonists of gonadotropin releasing hormone
11/27/1997	CA2254756A1 Antagonists of gonadotropin releasing hormone
11/27/1997	CA2253541A1 Human phospholipase inhibitor
11/27/1997	CA2252537A1 Benzofuran carboxamides and their therapeutic use
11/26/1997	EP0808626A1 Use of acetyl-L-carnitine for the treatment of presenile Alzheimer's disease
11/26/1997	EP0808325A1 Androstane and pregnane series for allosteric modulation of gaba receptor
11/26/1997	EP0808316A1 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
11/26/1997	EP0808314A1 New forms of paroxetin hydrochloride
11/26/1997	EP0808313A1 Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
11/26/1997	EP0808312A1 Indole derivatives as 5-ht receptor antagonist
11/26/1997	EP0808307A1 Bicyclic isothiourea derivatives useful in therapy
11/26/1997	EP0808170A1 Treatment of diabetic neuropathy
11/26/1997	EP0808165A1 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
11/26/1997	EP0700398B1 Psoralen derivatives, their preparation and use as medicaments
11/26/1997	CN1166173A Tetrahydropyridine-(or 4-hydroxypiperidine) Alkylazoles having an affinity for sigma and/or 5HTIA receptors
11/26/1997	CN1166169A Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors
11/26/1997	CN1166167A Novel prostaglandin synthase inhibitors
11/26/1997	CN1165655A Method of treating conditions with estrogen agonists
11/26/1997	CN1165651A Use of (E)-1£4'-(2-alkylaminoethioxy) phenyl\|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions
11/26/1997	CN1165650A 1,1,2-triphenylbut-1-ene derivatives for treating alzheimer's disease
11/25/1997	US5691374 Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
11/25/1997	US5691368 Therapy for neurodegenerative disorders
11/25/1997	US5691358 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides
11/25/1997	US5691353 Method of inhibiting aortal smooth muscle cell proliferation using naphthyl compounds
11/25/1997	US5691347 Angiotensin ii inhibitors and vasoconstriction
11/25/1997	US5691344 Vasoconstrictive substituted dihydropyranopyridines
11/25/1997	US5691340 Benzopyran derivatives
11/25/1997	US5691336 Morpholine compounds are prodrugs useful as tachykinin receptor antagonists
11/25/1997	US5691318 Nervous system disorders and medical diagnosis
11/25/1997	US5691201 Use of sabeluzole in chronic neurodegenerative diseases
11/25/1997	US5690927 Use of neuro-glial fetal cell lines for transplantation therapy
11/25/1997	CA2132541C Quinuclidine derivatives as substance p antagonists
11/25/1997	CA2101518C Neuroleptic perhydro-1h-pyrido¬1,2-a\|pyrazines
11/24/1997	CA2205940A1 Medicament comprising a carnitine derivative for treating alzheimer's disease in early-onset patients
11/20/1997	WO1997043649A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿
11/20/1997	WO1997043306A1 Neuroactive peptides
11/20/1997	WO1997043304A1 Novel compounds
11/20/1997	WO1997043303A1 Novel compounds
11/20/1997	WO1997043300A1 Adenosine derivatives
11/20/1997	WO1997043276A1 Novel 2,3 disubstituted-4(3h)-quinazolinones
11/20/1997	WO1997043272A2 Benzofurans and benzopyrans as chronobiological agents
11/20/1997	WO1997043271A1 Alkylaminobenzothiazole and -benzoxazole derivatives
11/20/1997	WO1997043262A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/20/1997	WO1997043259A1 Arylalkylpiperazine compounds as antioxidants
11/20/1997	WO1997043245A1 Inhibition of matrix metalloproteases by acetylene containing compounds
11/20/1997	WO1997043240A1 INHIBITION OF MATRIX METALLOPROTEASES BY 2-(φ-AROYLALKYL)-4-BIARYL-OXOBUTYRIC ACIDS
11/20/1997	WO1997043239A1 Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids
11/20/1997	WO1997042956A1 Didhydropyrimidines and uses thereof
11/20/1997	WO1997042941A2 Buccal delivery system
11/20/1997	WO1997042939A1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity
11/20/1997	WO1997035538A3 Tumor necrosis factor alpha convertase
11/20/1997	WO1997034587A3 Transdermal device
11/20/1997	CA2253927A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/20/1997	CA2253862A1 Dihydropyrimidines and uses thereof
11/20/1997	CA2253802A1 Benzofurans and benzopyrans as chronobiological agents
11/20/1997	CA2253566A1 Arylalkylpiperazine compounds as antioxidants
11/20/1997	CA2252583A1 Anticonvulsant pyridinyl benzamide derivatives
11/19/1997	EP0807686A2 Interleukin-1 beta converting enzyme like apoptotic protease-7
11/19/1997	EP0807684A1 Human G-protein coupled receptor (HIBCD07)
11/19/1997	EP0807633A2 Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
11/19/1997	EP0807621A1 Derivatives of phenylglycine and use thereof as pharmaceuticals
11/19/1997	EP0807122A1 Novel receptor
11/19/1997	EP0807111A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
11/19/1997	EP0807109A1 Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht 1d? receptor agonists

1 ... 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 ... 1833